#United States #San Antonio #Breast Cancer #SABCS

San Antonio Breast Cancer Symposium®: A Catalyst for Economic Growth and Research Advancement

The San Antonio Breast Cancer Symposium® (SABCS) has once again proven to be a significant force in the intersection of healthcare, research, and local economic growth. Drawing in over 11,000 attendees from around the globe to downtown San Antonio, this prestigious symposium generated nearly $40 million in economic impact.

Held annually in December at the Henry B. González Convention Center, SABCS plays a pivotal role in enhancing the city’s appeal as a leading destination for medical tourism, substantiating its thriving $21.5 billion tourism industry. Local businesses, from hotels to restaurants, benefit significantly from the influx of visitors, with $22.8 million reported in direct spending, alongside $1.5 million in tax revenue, ultimately supporting more than 6,800 jobs.

Dr. Virginia Kaklamani, co-chair of SABCS and head of the breast cancer program at the Mays Cancer Center, remarked, "The San Antonio Breast Cancer Symposium is a powerful driver of economic growth for our city. Here, new discoveries are shared, tested, and translated into better care for patients while supporting local businesses."

A Historical Perspective

SABCS has enjoyed a remarkable trajectory since its inception in 1977, where a modest gathering of just 50 attendees marked the beginning of a monumental collaborative effort in breast cancer research. Fast forward to today, and the symposium has evolved into a premier forum for oncologists, researchers, and patient advocates from over 104 countries, facilitating invaluable exchanges in scientific evidence and clinical practices.

Dr. Lei Zheng, executive director of the Mays Cancer Center, emphasized the symposium's vital role in fostering global partnerships. "For decades, this meeting has positioned San Antonio at the center of global collaboration in breast cancer research. It reflects our institution’s commitment to excellence in research and to advancing prevention and early detection."

Focus on Emerging Priorities in Breast Cancer Care

SABCS 2025 also addressed emergent priorities in breast cancer care, such as the specific needs of younger patients, lifestyle impacts including nutrition, and strategies targeting obesity-related cancer risks. Meanwhile, medical fellows from UT Health San Antonio presented groundbreaking research on GLP-1 weight loss medications and their potential influence on breast cancer treatment responses and side effects.

Margaret Foti, chief executive officer of the American Association for Cancer Research (AACR), noted, "We are extraordinarily proud to partner with UT Health San Antonio and the Mays Cancer Center on SABCS. This symposium serves as a forum and, in many ways, a catalyst for innovative research that has led to enormous progress for patients."

Innovations in Patient Care

Research shared during SABCS 2025 is already having a transformative effect on patient care. Recent advancements include:

• - An Oral Therapy for Early-stage Breast Cancer: Giredestrant has demonstrated increased survival rates without cancer recurrence, surpassing standard hormone treatments.
• - Chemotherapy-free Treatments for Advanced HER2-positive Disease: The addition of tucatinib in treatment regimens has prolonged progression-free survival, showing remarkable improvements in treatment outcomes without extensive reliance on chemotherapy.
• - Vaccination Strategies for Aggressive Breast Cancer Types: Early trials suggest an innovative immune response strategy in triple-negative breast cancer, exhibiting promising results in 74% of participants.

Dr. Kate Lathrop, associate clinical professor and breast medical oncologist at the Mays Cancer Center, expressed her enthusiasm for the advancements being made. "We're seeing exciting new approaches, from targeted treatments to prevention strategies that are already beginning to change what's possible for patients."

As the symposium gears up for its 49th annual event, scheduled for December 8-11, 2026, it continues to strengthen its position as a leading forum for breast cancer research and care.

For more information, visit sabcs.org.

In conclusion, the San Antonio Breast Cancer Symposium represents more than just a meeting; it is a crucial hub for innovative research that drives economic growth and advances patient care, reinforcing San Antonio’s role in the global healthcare landscape.